Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice

Abstract Background Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with canagliflozin on bioche...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Νarjes Nasiri-Ansari, Georgios K. Dimitriadis, Georgios Agrogiannis, Despoina Perrea, Ioannis D. Kostakis, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva, Eva Kassi
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2018-07-01
Series:Cardiovascular Diabetology
Assuntos:
Canagliflozin
SGLT2i
Atherosclerosis
Inflammation
APOE knockout mice
Acceso en liña:http://link.springer.com/article/10.1186/s12933-018-0749-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares